Page last updated: 2024-10-30

mefenamic acid and Cancer of Liver

mefenamic acid has been researched along with Cancer of Liver in 1 studies

Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"We used Chang and Huh-7 cells as human liver cancer cells."1.32Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathway. ( Han, IS; Jung, G; Woo, DH, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Woo, DH1
Han, IS1
Jung, G1

Other Studies

1 other study available for mefenamic acid and Cancer of Liver

ArticleYear
Mefenamic acid-induced apoptosis in human liver cancer cell-lines through caspase-3 pathway.
    Life sciences, 2004, Oct-01, Volume: 75, Issue:20

    Topics: Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Caspases; Enzyme Inhibito

2004